Associations between smoking and extra-axial manifestations and disease severity in axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register for Ankylosing Spondylitis (BSRBR-AS)



Zhao, S ORCID: 0000-0002-3558-7353, Jones, Gareth T, Macfarlane, Gary J, Hughes, David M ORCID: 0000-0002-1287-9994, Dean, Linda E, Moots, Robert J ORCID: 0000-0001-7019-6211 and Goodson, Nicola ORCID: 0000-0003-0714-3568
(2019) Associations between smoking and extra-axial manifestations and disease severity in axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register for Ankylosing Spondylitis (BSRBR-AS). Rheumatology, 58 (5). pp. 811-819.

This is the latest version of this item.

[img] Text
Maintext_RHE-18-1124.R1_EdOffice_changes.pdf - Author Accepted Manuscript

Download (364kB)
[img] Text
Supp_materials_RHE-18-1124.R1.docx - Author Accepted Manuscript

Download (57kB)

Abstract

Objective The effects of smoking on disease manifestations in axial SpA are inadequately described. Utilizing a large and well-characterized cohort, we investigated the association between smoking and extra-axial manifestations, and smoking and disease severity measures. Methods Baseline data from the British Society for Rheumatology Biologics Register for Ankylosing Spondylitis were explored. Our analyses focused on extra-axial manifestations and other disease severity measures, including scales for fatigue, sleep, anxiety and depression. Logistic and linear models were used to quantify associations between disease characteristics according to smoking status (current/ex/never) and quantity (heavy/light), adjusting for age, gender, BMI, education, deprivation, comorbidities, symptom duration and alcohol status. Results A total of 2031 participants were eligible for the current analysis (68% male, mean age 49 years). Of these, 24% were current and 32% ex-smokers. When compared with non-smokers, current smokers had lower odds of uveitis [OR 0.7, 95% CI 0.5–0.9] and higher odds of psoriasis (ORadj 1.6, 95% CI 1.1–2.3). Ex- and current smokers had incrementally more severe disease than never smokers, with higher BASDAI (β = 0.3, 95% CI 0.1–0.6; β = 0.9, 95% CI 0.6–1.2) and BASFI (β = 0.5, 95% CI 0.2–0.8; β = 1.3, 95% CI 1.0–1.6); similar associations were observed for fatigue, sleep, anxiety and depression. Conclusion In this large cross-sectional study, we observed that smoking is independently associated with an adverse disease profile in axial SpA, including worse fatigue, sleep, anxiety and depression, and higher odds of psoriasis. The paradoxical association between current smoking and reduced odds of uveitis is interesting and warrants further investigation.

Item Type: Article
Uncontrolled Keywords: axial spondyloarthritis, ankylosing spondylitis, smoking, uveitis, extra-axial manifestations, registry, fatigue, sleep, psoriasis, depression
Depositing User: Symplectic Admin
Date Deposited: 18 Feb 2019 10:35
Last Modified: 19 Jan 2023 01:03
DOI: 10.1093/rheumatology/key371
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3033036

Available Versions of this Item